-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
SINGAPORE, Nov.
In 2020, the incidence of ovarian cancer in Asia accounted for more than half (54.
About one in two patients with advanced ovarian cancer is HRD-positive
AstraZeneca has been actively developing medical innovation partnerships and has launched the A.
Vinod Narayanan, President of AstraZeneca Singapore, said: "Our partnership with Luson underscores AstraZeneca's continued drive to combine the expertise of medical technology innovators to help patients with chronic conditions including diabetes, heart disease and cancer
"We are delighted to offer this test to cancer patients and doctors in Southeast Asia," said Dr.
About AstraZeneca
AstraZeneca is a science-first global biopharmaceutical company focused on the research and development, production and marketing of prescription medicines, with a focus on three major disease areas: oncology, cardiovascular, renal and metabolic, respiratory and immune
About Lusheng
Lusheng is a precision medicine company developing and applying ultra-sensitive liquid biopsy technology to enable early cancer detection and improve treatment options